Olema Pharmaceuticals (OLMA) Analyst & Key Data

Analyst Consensus

Buy15 analysts

Buy

Updated Sep 12, 2026

Total Analysts15

Buy

8

Ratings

Updated Sep 12, 2026

Overall Rating

C+

DCF Score3.0 / 5

Debt / Equity Score4.0 / 5

Price / Book Score2.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$10.22

Median Target+258.81%

$36.67

Potential upside vs current price

DCF Value-95.21%

$0.49

Potential downside vs current price

Current Stock Price

$10.22

Median Target+258.81%

$36.67

Potential upside vs current price

DCF Value-95.21%

$0.49

Potential downside vs current price

Analyst Consensus

Buy15 analysts

Buy

Updated Sep 12, 2026

Total Analysts15

Buy

8

Ratings

Updated Sep 12, 2026

Overall Rating

C+

DCF Score3.0 / 5

Debt / Equity Score4.0 / 5

Price / Book Score2.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$10.22

Median Target+258.81%

$36.67

Potential upside vs current price

DCF Value-95.21%

$0.49

Potential downside vs current price

Current Stock Price

$10.22

Median Target+258.81%

$36.67

Potential upside vs current price

DCF Value-95.21%

$0.49

Potential downside vs current price

Olema Pharmaceuticals, Inc.